Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Grenier, , Pauline,
DOB: 03-MAY-1971 (Age: 54)
Gender: female
Address:
114, avenue Georges
71110 Caron (France)
ID: 6776-872657-1 (ECI)
Report
Date: 06-MAR-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Hôpital du Creusot - Site Foch
71200 Le Creusot (France)
Specimen
Collected: 06-MAR-2023

Chemistry

Test 06-MAR-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.1 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 95.7 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 12.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.6 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 108.0 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 28.8 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 149.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 103.7 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 68.9 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 59.9 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All parameters are within normal limits except for a mildly elevated HbA1c (6.1%), indicating prediabetes. Glucose is currently normal. Renal function, electrolytes, and lipid profile are unremarkable. Recommend monitoring glycemic control and considering lifestyle modifications to prevent progression to diabetes. No other laboratory abnormalities detected.